Factor-binding element in the human c-myc promoter involved in transcriptional regulation by transforming growth factor beta 1 and by the retinoblastoma gene product.
J. A. Pietenpol , K. Munger , P. M. Howley , R. W. Stein
Proceedings of the National Academy of Sciences of the United States of America 88 ( 22) 10227 -10231
106
1991
Transforming growth factor beta 1 suppression of c-myc gene transcription: role in inhibition of keratinocyte proliferation.
J. A. Pietenpol , J. T. Holt , R. W. Stein , H. L. Moses
Proceedings of the National Academy of Sciences of the United States of America 87 ( 10) 3758 -3762
567
1990
Neoadjuvant paclitaxel/radiation for Stage II/III breast cancer with correlative molecular markers
A. Chakravarthy , P. Chaurand , B. McLaren , M. Kelley
Journal of Clinical Oncology 22 9622 -9622
2
2004
The jury is in: p73 is a tumor suppressor after all
J. M. Rosenbluth , J. A. Pietenpol
Genes & Development 22 ( 19) 2591 -2595
43
2008
Sequence-specific transcriptional activation is essential for growth suppression by p53.
J. A. Pietenpol , T. Tokino , S. Thiagalingam , W. S. el-Deiry
Proceedings of the National Academy of Sciences of the United States of America 91 ( 6) 1998 -2002
367
1994
Transforming Growth Factor Regulation of Keratinocyte Growth
L. Dagnino , J. A. Pietenpol , E. Y. Yang , H. L. Moses
Recent results in cancer research 128 15 -29
15
1993
A phase II neoadjuvant study of cisplatin/paclitaxel with or without RAD001 in patients with triple-negative (TN) locally advanced breast cancer (BC).
I. A. Mayer , I. M. Meszoely , M. Sanders , Y. Shyr
Journal of Clinical Oncology 28
2010
Mammalian cells resistant to tumor suppressor genes
J. A. Pietenpol , C. Lengauer , J. Jordan , K. W. Kinzler
Proceedings of the National Academy of Sciences of the United States of America 93 ( 16) 8390 -8394
8
1996
Regulation of Fibroblastic and Epithelial Cell Function by Transforming Growth Factors
H. L. Moses , J. A. Barnard , C. C. Bascom , R. D. Beauchamp
New Concepts in Cancer 218 -230
2
1990
Five-year results of preoperative concurrent paclitaxel with radiation in locally advanced breast cancer (LABC).
S. Formenti , S. Adams , A. B. Chakravarthy , S. C. Lymberis
Journal of Clinical Oncology 28 567 -567
1
2010
Predictors of pathologic response and correlation with long-term outcomes in a trial of neoadjuvant concurrent paclitaxel radiation in locally advanced breast cancer (LABC).
S. Adams , S. C. Lymberis , A. B. Chakravarthy , D. V. Spicer
Journal of Clinical Oncology 28 589 -589
2010
c-myc and pRB: Role in TGF-β1 Inhibition of Keratinocyte Proliferation
C.S. Murphy , J.A. Pietenpol , K. Munger , P.M. Howley
Cold Spring Harbor Symposia on Quantitative Biology 56 129 -135
22
1991
Synthetic Lethal Relationships in the DNA Damage Response of Triple Negative Breast Cancer
M.P. Greenbaum , T.D. Wiltshire , G.G. Glick , J.A. Bauer
International Journal of Radiation Oncology*Biology*Physics 81 ( 2) S26
2011
Five-year Local Control Results of Preoperative Paclitaxel with Concurrent Radiation Therapy in Locally Advanced Breast Cancer
A. Chakravarthy , S. Adams , D. Spicer , S. Lymberis
International Journal of Radiation Oncology Biology Physics 78 ( 3)
2010
Five-year Results of Preoperative Paclitaxel with Concurrent Radiation Therapy in Locally Advanced Breast Cancer: Pathological Response Predicts for Survival
R.J. Schneider , S.C. Formenti , A. Chakravarthy , S. Adams
International Journal of Radiation Oncology Biology Physics 78 ( 3)
2010
Trend Towards Improved Survival in Triple Negative Stage II/III Breast Cancer Patients Treated With Preoperative Concurrent Paclitaxel and Radiation
J.J. Meshman , A.A. Weiner , G.D. Ayers , J.A. Bauer
International Journal of Radiation Oncology Biology Physics 93 ( 3)
2015
Abstract PD01-07: Transcriptome Analysis of Triple Negative Breast Cancers Identifies Six Distinct Biological Subgroups and Reveals Therapeutic Strategies
BD Lehmann , JA Bauer , X Chen , ME Sanders
Cancer Research 70
5
2010
p73 Is Required for Multiciliogenesis and Regulates the Foxj1-Associated Gene Network
Clayton B. Marshall , Deborah J. Mays , J. Scott Beeler , Jennifer M. Rosenbluth
Cell Reports 14 ( 10) 2289 -2300
117
2016
A Phase Ib Trial of RAD001, an mTOR Inhibitor, with Weekly Cisplatin and Paclitaxel in Patients with HER2-Negative Metastatic Breast Cancer.
I. Mayer , H. Burris , J. Bendell , J. Means-Powell
Cancer Research 69 3093 -3093
18
2009
Oncogenic forms of p53 inhibit p53-regulated gene expression
S. Kern , J. Pietenpol , S Thiagalingam , A Seymour
Science 256 ( 5058) 827 -830
856
1992